Fifth Third Bancorp
2.98xPrice / tangible book
Market cap
$49.76B
Tangible equity
$16.71B
Price / tangible book
2.98x
Price / book
2.29x
Return on equity
11.6%
Return on assets
1.2%
Efficiency ratio
39.8%
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FITB stock price at discount vs LGND $54.87 current versus $164.46 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LGND's multiple
Implied fair value · at FITB's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Multiple discount
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: FITB FY 2025 (ended Dec 31, 2025) · LGND FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$49.76B
Tangible equity
$16.71B
Price / tangible book
2.98x
Price / book
2.29x
Return on equity
11.6%
Return on assets
1.2%
Efficiency ratio
39.8%
Price / tangible book
Market cap
$5.69B
Tangible equity
$690.23M
Price / tangible book
8.25x
Price / book
5.60x
Return on equity
12.2%
Return on assets
8.0%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FIFTH THIRD BANCORP · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
LIGAND PHARMACEUTICALS INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.67x
0.37x
Net debt / EBITDA
Leverage against operating earnings
—
-2.24x
Cash and equivalents
Liquid reserves on the balance sheet
—
$733.52M
Total debt
Interest-bearing obligations outstanding
$14.52B
$374.08M
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
FITB vs JPM
Bank of America Corporation
FITB vs BAC
Wells Fargo & Company
FITB vs WFC
PNC FINANCIAL SERVICES GROUP, INC.
FITB vs PNC
TRUIST FINANCIAL CORP
FITB vs TFC
Royalty Pharma plc
FITB vs RPRX
Sarepta Therapeutics, Inc.
FITB vs SRPT
INCYTE CORP
FITB vs INCY
EXELIXIS, INC.
FITB vs EXEL
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.